{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:34:50Z","timestamp":1772120090435,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/04166-7; 2015-03053-3"],"award-info":[{"award-number":["2021\/04166-7; 2015-03053-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/04166-7; 2015-03053-3"],"award-info":[{"award-number":["2021\/04166-7; 2015-03053-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302434\/2019-4"],"award-info":[{"award-number":["302434\/2019-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12640-024-00720-4","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:11:42Z","timestamp":1728000702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of 5-Lipoxygenase Deficiency on Dopamine-Mediated Behavioral Responses"],"prefix":"10.1007","volume":"42","author":[{"given":"Ana Carolina","family":"Issy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Francisco","family":"Pedrazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glauce Crivelaro","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00facia Helena","family":"Faccioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Del Bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"720_CR1","doi-asserted-by":"publisher","unstructured":"Arias-Carri\u00f3n O, Stamelou M, Murillo-Rodr\u00edguez E, Men\u00e9ndez-Gonz\u00e1lez M, P\u00f6ppel E (2010) Dopaminergic reward system: a short integrative review. Int Arch Med 3:24. https:\/\/doi.org\/10.1186\/1755-7682-3-24","DOI":"10.1186\/1755-7682-3-24"},{"key":"720_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbi.2021.12.004","volume":"100","author":"MC Barbosa-Silva","year":"2022","unstructured":"Barbosa-Silva MC, Campos P, Del Castilo RM, Fran\u00e7a I, Frost JV, Penido PS et al (2022) Mice lacking 5-lipoxygenase display motor deficits associated with cortical and hippocampal synapse abnormalities. Brain Behav Immun 100:183\u2013193. https:\/\/doi.org\/10.1016\/j.bbi.2021.12.004","journal-title":"Brain Behav Immun"},{"issue":"3","key":"720_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0304-3940(95)11482-c","volume":"189","author":"MK Bendani","year":"1995","unstructured":"Bendani MK, Palluy O, Cook-Moreau J, Beneytout JL, Rigaud M, Vallat JM (1995) Localization of 12-lipoxygenase mRNA in cultured oligodendrocytes and astrocytes by in situ reverse transcriptase and polymerase chain reaction. Neurosci Lett 189(3):159\u2013162. https:\/\/doi.org\/10.1016\/0304-3940(95)11482-c","journal-title":"Neurosci Lett"},{"issue":"1","key":"720_CR4","doi-asserted-by":"publisher","first-page":"CD000204","DOI":"10.1002\/14651858.CD000204.pub2","volume":"1","author":"H Bergman","year":"2018","unstructured":"Bergman H, Soares-Weiser K (2018) Anticholinergic medication for antipsychotic-induced tardive dyskinesia. Cochrane Database Syst Rev 1(1):CD000204. https:\/\/doi.org\/10.1002\/14651858.CD000204.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"720_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/neuro.08.014.2009","volume":"3","author":"SD Bilbo","year":"2009","unstructured":"Bilbo SD, Schwarz JM (2009) Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci 3:14","journal-title":"Front Behav Neurosci"},{"key":"720_CR6","first-page":"S60","volume":"47","author":"P Calabresi","year":"2000","unstructured":"Calabresi P, Giacomini P, Centonze D, Bernardi G (2000) Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? Ann Neurol 47:S60\u2013S69","journal-title":"Ann Neurol"},{"issue":"7\u20138","key":"720_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.neuropharm.2010.09.006","volume":"60","author":"H Chen","year":"2011","unstructured":"Chen H, Manev H (2011) Effects of minocycline on cocaine sensitization and phosphorylation of GluR1 receptors in 5-lipoxygenase deficient mice. Neuropharmacology 60(7\u20138):1058\u20131063. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.09.006","journal-title":"Neuropharmacology"},{"issue":"228","key":"720_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neuroscience.2012.10.009","volume":"3","author":"VP Chou","year":"2013","unstructured":"Chou VP, Holman TR, Manning-Bog AB (2013) Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability. Neurosci 3(228):73\u201382. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.10.009","journal-title":"Neurosci"},{"key":"720_CR9","doi-asserted-by":"publisher","first-page":"174657","DOI":"10.1155\/2009\/174657","volume":"2009","author":"J Chu","year":"2009","unstructured":"Chu J, Pratic\u00f2 D (2009) The 5-lipoxygenase as a common pathway for pathological brain and vascular aging. Cardiovasc Psychiatr Neurol 2009:174657. https:\/\/doi.org\/10.1155\/2009\/174657","journal-title":"Cardiovasc Psychiatr Neurol"},{"key":"720_CR10","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.ajpath.2010.12.032","volume":"178","author":"J Chu","year":"2011","unstructured":"Chu J, Pratic\u00f2 D (2011) Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzeheimer\u2019s disease transgenic mouse model involvement of gamma-secretase. Am J Path 178:1762\u20131769","journal-title":"Am J Path"},{"issue":"2","key":"720_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.brainresbull.2016.03.010","volume":"126","author":"J Chu","year":"2016","unstructured":"Chu J, Pratic\u00f2 D (2016) The 5-Lipoxygenase as modulator of Alzheimer\u2019s \u03b3-secretase and therapeutic target. Brain Res Bull 126(2):207\u2013212. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.03.010","journal-title":"Brain Res Bull"},{"issue":"312","key":"720_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbr.2016.06.014","volume":"1","author":"AS Cunha","year":"2016","unstructured":"Cunha AS, Matheus FC, Moretti M, Sampaio TB, Poli A, Santos DB et al (2016) Agmatine attenuates reserpine-induced oral dyskinesia in mice: role of oxidative stress, nitric oxide and glutamate NMDA receptors. Behav Brain Res 1(312):64\u201376. https:\/\/doi.org\/10.1016\/j.bbr.2016.06.014","journal-title":"Behav Brain Res"},{"issue":"1","key":"720_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.coph.2006.11.003","volume":"7","author":"G Di Chiara","year":"2007","unstructured":"Di Chiara G, Bassareo V (2007) Reward system and addiction: what dopamine does and doesn\u2019t do. Curr Opin Pharmacol 7(1):69\u201376","journal-title":"Curr Opin Pharmacol"},{"key":"720_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1742-2094-9-71","volume":"9","author":"Y Diz-Chaves","year":"2012","unstructured":"Diz-Chaves Y, Pern\u00eda O, Carrero P, Garcia-Segura LM (2012) Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice.\u00a0J. Neuroinflammation\u00a09:71. https:\/\/doi.org\/10.1186\/1742-2094-9-71","journal-title":"Journal of neuroinflammation"},{"issue":"3","key":"720_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s12640-021-00345-x","volume":"39","author":"DP Ferrari","year":"2021","unstructured":"Ferrari DP, Bortolanza M, Del Bel EA (2021) Interferon-\u03b3 involvement in the Neuroinflammation Associated with Parkinson\u2019s disease and L-DOPA-Induced Dyskinesia. Neurotox Res 39(3):705\u2013719. https:\/\/doi.org\/10.1007\/s12640-021-00345-x","journal-title":"Neurotox Res"},{"key":"720_CR16","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-24","volume":"161","author":"CD Funk","year":"2000","unstructured":"Funk CD, Chen XS (2000) 5-Lipoxygenase and Leukotrienes Transgenic Mouse and Nuclear Targeting studies. Am J Respir Crit Care Med 161:S120\u2013S124 Internet address: www.atsjournals.org","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"720_CR17","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s12035-018-1124-7","volume":"56","author":"PF Giannopoulos","year":"2019","unstructured":"Giannopoulos PF, Chiu J, Pratic\u00f2 D (2019) Learning impairments, memory deficits, and neuropathology in aged tau transgenic mice are dependent on Leukotrienes Biosynthesis: role of the cdk5 kinase pathway. Mol Neurobiol 56(2):1211\u20131220. https:\/\/doi.org\/10.1007\/s12035-018-1124-7","journal-title":"Mol Neurobiol"},{"key":"720_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.bbi.2018.11.315","volume":"76","author":"DR Goldsmith","year":"2019","unstructured":"Goldsmith DR, Haroon E, Miller AH, Addington J, Bearden C, Cadenhead K et al (2019) Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis. Brain Behav Immun 76:268\u2013274. https:\/\/doi.org\/10.1016\/j.bbi.2018.11.315","journal-title":"Brain Behav Immun"},{"issue":"2","key":"720_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.bbr.2009.08.003","volume":"205","author":"AC Issy","year":"2009","unstructured":"Issy AC, Salum C, Del Bel EA (2009) Nitric oxide modulation of methylphenidate-induced disruption of prepulse inhibition in Swiss mice. Behav Brain Reseasch 205(2):475\u2013481. https:\/\/doi.org\/10.1016\/j.bbr.2009.08.003","journal-title":"Behav Brain Reseasch"},{"issue":"350","key":"720_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbr.2018.05.002","volume":"17","author":"AC Issy","year":"2018","unstructured":"Issy AC, Nascimento GC, Abreu GHD, Trist\u00e3o FS, Del-Bel E, Duarte T et al (2018) Differential behavioral and glial responses induced by dopaminergic mechanisms in the iNOS knockout mice. Behav Brain Res 17(350):44\u201353. https:\/\/doi.org\/10.1016\/j.bbr.2018.05.002","journal-title":"Behav Brain Res"},{"issue":"4","key":"720_CR21","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s12640-020-00268-z","volume":"38","author":"AC Issy","year":"2020","unstructured":"Issy AC, Pedrazzi JFC, van Oosten ABS, Checheto T, Silva RR, No\u00ebl F et al (2020) Effects of doxycycline in Swiss mice predictive models of Schizophrenia. Neurotox Res 38(4):1049\u20131060. https:\/\/doi.org\/10.1007\/s12640-020-00268-z","journal-title":"Neurotox Res"},{"issue":"Suppl 1","key":"720_CR22","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.parkreldis.2016.12.003","volume":"33","author":"P Jenner","year":"2016","unstructured":"Jenner P, Katzenschlager R (2016) Apomorphine - pharmacological properties and clinical trials in Parkinson\u2019s disease. Parkinsonism Relat Disord 33(Suppl 1):S13\u2013S21. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.12.003","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"720_CR23","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jpsychires.2012.12.011","volume":"47","author":"YB Joshi","year":"2013","unstructured":"Joshi YB, Pratic\u00f2 D (2013) The involvement of 5-lipoxygenase activating protein in anxiety-like behavior. J Psychiatr Res 47(5):694\u2013698. https:\/\/doi.org\/10.1016\/j.jpsychires.2012.12.011","journal-title":"J Psychiatr Res"},{"issue":"2","key":"720_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bcp.2013.05.005","volume":"86","author":"AS Kahnt","year":"2013","unstructured":"Kahnt AS, R\u00f6rsch F, Diehl O, Hofmann B, Lehmann C, Steinbrink SD et al (2013) Cysteinyl leukotriene-receptor-1 antagonists interfere with PGE2 synthesis by inhibiting mPGES-1 activity. Biochem Pharmacol 86(2):286\u2013296. https:\/\/doi.org\/10.1016\/j.bcp.2013.05.005","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"720_CR25","doi-asserted-by":"publisher","first-page":"782584","DOI":"10.3389\/fphar.2021.782584","volume":"21","author":"AS Kahnt","year":"2022","unstructured":"Kahnt AS, Angioni C, G\u00f6bel T, Hofmann B, Roos J, Steinbrink SD et al (2022) Inhibitors of human 5-Lipoxygenase potently interfere with prostaglandin transport. Front Pharmacol 21(12):782584. https:\/\/doi.org\/10.3389\/fphar.2021.782584","journal-title":"Front Pharmacol"},{"key":"720_CR26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuropharm.2013.06.014","volume":"73","author":"KH Kang","year":"2013","unstructured":"Kang KH, Liou HH, Hour MJ, Liou HC, Fu WM (2013) Protection of dopaminergic neurons by 5-lipoxygenase inhibitor. Neuropharmacology 73:380\u2013387. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.014","journal-title":"Neuropharmacology"},{"issue":"1","key":"720_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0952-3278(95)90082-9","volume":"53","author":"T Kerttula","year":"1995","unstructured":"Kerttula T, Riutta A, Kaukinen S, Mets\u00e4-Ketel\u00e4 T, Sepp\u00e4l\u00e4 E, Vapaatalo H et al (1995) Noradrenaline and dopamine infusions modulate arachidonic acid cyclooxygenase and 5-lipoxygenase pathways ex vivo in man. Prostaglandins Leukot Essent Fat Acids 53(1):47\u201352. https:\/\/doi.org\/10.1016\/0952-3278(95)90082-9","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"1","key":"720_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s40478-020-01083-5","volume":"8","author":"A Kouli","year":"2020","unstructured":"Kouli A, Camacho M, Allinson K, Williams-Gray CH (2020) Neuroinflammation and protein pathology in Parkinson\u2019s disease dementia. Acta Neuropathol Commun 8(1):211. https:\/\/doi.org\/10.1186\/s40478-020-01083-5","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"720_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2174\/1871527320666210512013648","volume":"21","author":"O Kursun","year":"2022","unstructured":"Kursun O, Karatas H, Bariskaner H, Ozturk S (2022) Arachidonic acid metabolites in neurologic disorders. CNS Neurol Disord Drug Targets 21(2):150\u2013159. https:\/\/doi.org\/10.2174\/1871527320666210512013648","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"3","key":"720_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00702-007-0848-8","volume":"115","author":"M Kurtuncu","year":"2008","unstructured":"Kurtuncu M, Battista N, Uz T, D\u2019Agostino A, Dimitrijevic N, Pasquariello N et al (2008) Effects of cocaine in 5-lipoxygenase-deficient mice. J Neural Transm 115(3):389\u2013395. https:\/\/doi.org\/10.1007\/s00702-007-0848-8","journal-title":"J Neural Transm"},{"issue":"7","key":"720_CR31","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/glia.22496","volume":"61","author":"M Lazzarini","year":"2013","unstructured":"Lazzarini M, Martin S, Mitkovski M, Vozari RR, St\u00fchmer W, Bel ED (2013) Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model. Glia 61(7):1084\u20131100. https:\/\/doi.org\/10.1002\/glia.22496","journal-title":"Glia"},{"key":"720_CR32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJM199009063231006","volume":"323","author":"RA Lewis","year":"1990","unstructured":"Lewis RA, Austen KF, Soberman RJ (1990) Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N Engl J Med 323:645\u2013655","journal-title":"N Engl J Med"},{"issue":"1","key":"720_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2008.08.053","volume":"445","author":"Z Li","year":"2008","unstructured":"Li Z, Choi DY, Shin EJ, Hunter RL, Jin CH, Wie MB et al (2008) Phenidone protects the nigral dopaminergic neurons from LPS-induced neurotoxicity. Neurosci Lett 445(1):1\u20136. https:\/\/doi.org\/10.1016\/j.neulet.2008.08.053","journal-title":"Neurosci Lett"},{"key":"720_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fnbeh.2019.00073","volume":"16","author":"GA Locachevic","year":"2019","unstructured":"Locachevic GA, Prado MKB, Zoccal KF, Pereira PAT, Sorgi CA, Bortolanza M et al (2019) Paradoxical effect of LTB4 on the regulation of stress-Induced corticosterone production. Front Behav Neurosci 16:13\u201373. https:\/\/doi.org\/10.3389\/fnbeh.2019.00073","journal-title":"Front Behav Neurosci"},{"key":"720_CR35","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.mehy.2005.09.031","volume":"66","author":"H Manev","year":"2006","unstructured":"Manev H, Manev R (2006) 5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer\u2019s disease. Med Hypotheses 66:501\u2013503","journal-title":"Med Hypotheses"},{"key":"720_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1749-6632.2001.tb03610.x","volume":"939","author":"H Manev","year":"2001","unstructured":"Manev H, Uz T, Manev R, Zhang Z (2001) Neurogenesis and neuroprotection in the adult brain. A putative role for 5-lipoxygenase? Ann N Y Acad Sci 939:45\u201351","journal-title":"Ann N Y Acad Sci"},{"key":"720_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.pnpbp.2010.07.032","volume":"35","author":"H Manev","year":"2011","unstructured":"Manev H, Chen H, Dzitoyeva S, Manev R (2011) Cyclooxygenases and 5-lipoxygenase in Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatr 35:315\u2013319","journal-title":"Prog Neuropsychopharmacol Biol Psychiatr"},{"key":"720_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.schres.2017.08.027","volume":"195","author":"BJ Miller","year":"2018","unstructured":"Miller BJ, Buckley PF, McEvoy JP (2018) Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. Schizophr Res 195:275\u2013282. https:\/\/doi.org\/10.1016\/j.schres.2017.08.027","journal-title":"Schizophr Res"},{"key":"720_CR39","unstructured":"Paxinos G, Franklin KBJ (2019) Paxinos and Franklin\u2019s the mouse brain in stereotaxic coordinates, 5th edn. Elsevier"},{"issue":"2","key":"720_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainresrev.2006.02.002","volume":"52","author":"JW Phillis","year":"2006","unstructured":"Phillis JW, Horrocks LA, Farooqui AA (2006) Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res Rev 52(2):201\u2013243. https:\/\/doi.org\/10.1016\/j.brainresrev.2006.02.002","journal-title":"Brain Res Rev"},{"issue":"2","key":"720_CR41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1176\/jnp.13.2.304","volume":"13","author":"T Qu","year":"2001","unstructured":"Qu T, Manev R, Manev H (2001) 5-Lipoxygenase (5-LOX) promoter polymorphism in patients with early-onset and late-onset Alzheimer\u2019s disease. J Neuropsychiatry Clin Neurosci 13(2):304\u2013305. https:\/\/doi.org\/10.1176\/jnp.13.2.304","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"12","key":"720_CR42","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s00210-020-01923-0","volume":"393","author":"JB Reinheimer","year":"2020","unstructured":"Reinheimer JB, Bressan GN, de Freitas CM, Ceretta APC, Krum BN, Nogara PA et al (2020) Effects of CATECHIN on reserpine-induced vacuous chewing movements: behavioral and biochemical analysis. Naunyn Schmiedebergs Arch Pharmacol 393(12):2439\u20132452. https:\/\/doi.org\/10.1007\/s00210-020-01923-0","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"720_CR43","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1476-5381.2010.00930.x","volume":"161","author":"A Rossi","year":"2010","unstructured":"Rossi A, Pergola C, Koeberle A, Hoffmann M, Dehm F, Bramanti P et al (2010) The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. Br J Pharmacol 161(3):555\u2013570. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00930.x","journal-title":"Br J Pharmacol"},{"key":"720_CR44","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-1","volume":"161","author":"B Samuelsson","year":"2000","unstructured":"Samuelsson B (2000) The discovery of the leukotrienes. Am J Respir Crit Care Med 161:S2\u2013S6. https:\/\/doi.org\/10.1164\/ajrccm.161.supplement_1.ltta-1","journal-title":"Am J Respir Crit Care Med"},{"key":"720_CR45","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/intimm\/dxz044","volume":"31","author":"F Sasaki","year":"2019","unstructured":"Sasaki F, Yokomizo T (2019) The Leukotriene receptors as therapeutic targets of Inflammatory diseases. Int Immunol 31:607\u2013615","journal-title":"Int Immunol"},{"issue":"15","key":"720_CR46","doi-asserted-by":"publisher","first-page":"726893","DOI":"10.3389\/fncir.2021.726893","volume":"11","author":"GP Serra","year":"2021","unstructured":"Serra GP, Guillaumin A, Dumas S, Vlcek B, Wall\u00e9n-Mackenzie \u00c5 (2021) Midbrain dopamine neurons defined by TrpV1 modulate Psychomotor Behavior. Front Neural Circ 11(15):726893. https:\/\/doi.org\/10.3389\/fncir.2021.726893","journal-title":"Front Neural Circ"},{"issue":"1\u20132","key":"720_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0006-8993(81)90894-5","volume":"210","author":"JA Severson","year":"1981","unstructured":"Severson JA, Randall PK, Finch CE (1981) Genotypic influences on striatal dopaminergic regulation in mice. Brain Res 210(1\u20132):201\u2013215. https:\/\/doi.org\/10.1016\/0006-8993(81)90894-5","journal-title":"Brain Res"},{"issue":"3","key":"720_CR48","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/ejn.15566","volume":"55","author":"W Shen","year":"2022","unstructured":"Shen W, Jiang L, Zhao J, Wang H, Hu M, Chen L et al (2022) Bioactive lipids and their metabolism: New therapeutic opportunities for Parkinson\u2019s disease. Eur J Neurosci 55(3):846\u2013872. https:\/\/doi.org\/10.1111\/ejn.15566","journal-title":"Eur J Neurosci"},{"issue":"3","key":"720_CR49","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/biom12030346","volume":"12","author":"K Strempfl","year":"2022","unstructured":"Strempfl K, Unger MS, Flunkert S, Trost A, Reitsamer HA, Hutter-Paier B et al (2022) Leukotriene Signaling as a target in \u03b1-Synucleinopathies. Biomol 12(3):346. https:\/\/doi.org\/10.3390\/biom12030346","journal-title":"Biomol"},{"issue":"2\u20133","key":"720_CR50","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s002130100799","volume":"156","author":"NR Swerdlow","year":"2001","unstructured":"Swerdlow NR, Geyer MA, Braff DL (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacol 156(2\u20133):194\u2013215. https:\/\/doi.org\/10.1007\/s002130100799","journal-title":"Psychopharmacol"},{"key":"720_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.schres.2017.05.013","volume":"198","author":"NR Swerdlow","year":"2018","unstructured":"Swerdlow NR, Light GA, Thomas ML, Sprock J, Calkins ME, Green MF et al (2018) Deficient prepulse inhibition in schizophrenia in a multi-site cohort: internal replication and extension. Schizophr Res 198:6\u201315. https:\/\/doi.org\/10.1016\/j.schres.2017.05.013","journal-title":"Schizophr Res"},{"key":"720_CR52","first-page":"220","volume":"17","author":"D Tassoni","year":"2008","unstructured":"Tassoni D, Kaur G, Weisinger RS, Sinclair AJ (2008) The role of eicosanoids in the brain. Asia Pac J Clin Nutr 17:220\u2013228","journal-title":"Asia Pac J Clin Nutr"},{"issue":"3","key":"720_CR53","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s12640-015-9557-5","volume":"29","author":"FS Trist\u00e3o","year":"2016","unstructured":"Trist\u00e3o FS, Lazzarini M, Martin S, Amar M, St\u00fchmer W, Kirchhoff F et al (2016) CX3CR1 disruption differentially influences Dopaminergic Neuron Degeneration in Parkinsonian mice depending on the Neurotoxin and Route of Administration. Neurotoxicol Res 29(3):364\u2013380. https:\/\/doi.org\/10.1007\/s12640-015-9557-5","journal-title":"Neurotoxicol Res"},{"key":"720_CR54","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1046\/j.1471-4159.1999.0730693.x","volume":"73","author":"T Uz","year":"1999","unstructured":"Uz T, Dwivedi Y, Savani PD, Impagnatiello F, Pandey G, Manev H (1999) Glucocorticoids stimulate inflammatory 5-lipoxygenase gene expression and protein translocation in the brain. J Neurochem 73:693\u2013699. https:\/\/doi.org\/10.1046\/j.1471-4159.1999.0730693.x","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"720_CR55","first-page":"15","volume":"20","author":"T Uz","year":"2002","unstructured":"Uz T, Dimitrijevic N, Tueting P, Manev H (2002) 5-lipoxygenase (5LOX)-deficient mice express reduced anxiety-like behavior. Restor Neurol Neurosci 20(1\u20132):15\u201320 PMID: 12237493","journal-title":"Restor Neurol Neurosci"},{"key":"720_CR56","doi-asserted-by":"publisher","first-page":"35203","DOI":"10.1038\/srep35203","volume":"6","author":"T Viereckel","year":"2016","unstructured":"Viereckel T, Dumas S, Smith-Anttila CJA, Vlcek B, Bimpisidis Z, Lagerstr\u00f6m MC et al (2016) Midbrain gene screening identifies a new mesoaccumbal glutamatergic pathway and a marker for dopamine cells neuroprotected in Parkinson\u2019s disease. Sci Rep 6:35203","journal-title":"Sci Rep"},{"issue":"5","key":"720_CR57","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/MPA.0b013e318214c8df","volume":"40","author":"SR Vigna","year":"2011","unstructured":"Vigna SR, Shahid RA, Nathan JD, McVey DC, Liddle RA (2011) Leukotriene B4 mediates inflammation via TRPV1 in duct obstruction-induced pancreatitis in rats. Pancreas 40(5):708\u2013714. https:\/\/doi.org\/10.1097\/MPA.0b013e318214c8df","journal-title":"Pancreas"},{"issue":"11","key":"720_CR58","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.3390\/ijms22115606","volume":"22","author":"J Wallin","year":"2021","unstructured":"Wallin J, Svenningsson P (2021) Potential effects of Leukotriene receptor antagonist montelukast in treatment of Neuroinflammation in Parkinson\u2019s Disease. Int J Mol Sci 22(11):5606. https:\/\/doi.org\/10.3390\/ijms22115606","journal-title":"Int J Mol Sci"},{"key":"720_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2019.12.013","volume":"87","author":"Y Wang","year":"2020","unstructured":"Wang Y, Yang Y, Zhang S, Li C, Zhang L (2020) Modulation of Neuroinflammation by Cysteinyl Leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases. Neurobiol Aging 87:1\u201310","journal-title":"Neurobiol Aging"},{"key":"720_CR60","doi-asserted-by":"publisher","first-page":"101359","DOI":"10.1016\/j.arr.2021.101359","volume":"69","author":"M Yan","year":"2021","unstructured":"Yan M, Zhang S, Li C, Liu Y, Zhao J, Wang Y et al (2021) 5-Lipoxygenase as an emerging target against age-related brain disorders. Ageing Res Rev 69:101359. https:\/\/doi.org\/10.1016\/j.arr.2021.101359","journal-title":"Ageing Res Rev"},{"key":"720_CR61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.brainres.2014.05.026","volume":"1572","author":"XY Zhang","year":"2014","unstructured":"Zhang XY, Chen L, Yang Y, Xu DM, Zhang SR, Li CT et al (2014) Regulation of Rotenone-Induced Microglial activation by 5-Lipoxygenase and cysteinyl leukotriene receptor 1. Brain Res 1572:59\u201371","journal-title":"Brain Res"},{"key":"720_CR62","doi-asserted-by":"publisher","first-page":"10760","DOI":"10.1038\/ncomms10760","volume":"7","author":"KF Zoccal","year":"2016","unstructured":"Zoccal KF, Sorgi CA, Hori JI, Paula-Silva FWG, Arantes EC, Serezani CH et al (2016) Opposing roles of LTB4 and PGE2 in regulating the inflammasome-dependent scorpion venom-induced mortality. Nat Commun 7:10760. https:\/\/doi.org\/10.1038\/ncomms10760","journal-title":"Nat Commun"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-024-00720-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-024-00720-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-024-00720-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T13:05:40Z","timestamp":1729343140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-024-00720-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["720"],"URL":"https:\/\/doi.org\/10.1007\/s12640-024-00720-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4009886\/v1","asserted-by":"object"}]},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was carried out in accordance with the recommendations of National Council for Control of Animal Experimentation (CONCEA).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}}],"article-number":"42"}}